Clinical Trial Update: Campylobacter Jejuni Challenge Model Development: Dose Ranging Study [Phase 1]

View source ↗

Summary

A Phase 1 dose-ranging study to develop a Campylobacter jejuni challenge model, sponsored by the University of Vermont, focusing on Campylobacter infections. Th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Campylobacteriosis

Snippet

Sponsor: University of Vermont | Conditions: Campylobacter Infections | Phase 1 | Status: UNKNOWN